BioVaxys Technology

(OTC) BVAXF

Current Price$0.05

Market Cap$1.48M

Since IPO (2020)-98%

5 Year-98%

1 Year-80%

1 Month+1%

BioVaxys Technology Financials at a Glance

Market Cap

$1.48M

Revenue (TTM)

$0.00

Net Income (TTM)

$6.04M

EPS (TTM)

$-0.16

P/E Ratio

-0.32

Dividend

$0.00

Beta (Volatility)

0.19 (Low)

Dividend

$0.00

Beta (Volatility)

0.19 (Low)

Price

$0.05

Volume

35,803

Open

$0.04

Price

$0.05

Volume

35,803

Open

$0.04

Previous Close

$0.05

Daily Range

$0.04 - $0.06

52-Week Range

$0.02 - $0.34

Dividend

$0.00

Beta (Volatility)

0.19 (Low)

Price

$0.05

Volume

35,803

Open

$0.04

Previous Close

$0.05

Daily Range

$0.04 - $0.06

52-Week Range

$0.02 - $0.34

BVAXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioVaxys Technology

Industry

Pharmaceuticals

Sector

Health Care

CEO

James Christopher Passin

Website

www.biovaxys.com

Headquarters

Etobicoke, BC V6C 1L6, CA

BVAXF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

92%

Return on Assets

-4%

Earnings Yield

-3.13%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.48M

Shares Outstanding

29.15M

Volume

35.80K

Avg. Volume

101.01K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$3.12M

EBITDA

$0.00

Operating Cash Flow

$1.86M

Capital Expenditure

$1.06M

Free Cash Flow

$2.92M

Cash & ST Invst.

$211.81K

Total Debt

$68.08K

BioVaxys Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.48M

N/A

Market Cap/Employee

$494.63K

N/A

Employees

N/A

Net Income

$910.06K

+23.3%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$129.64K

-131.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$133.72K

+64.7%

Return on Assets

-4.36%

N/A

Return on Invested Capital

92.14%

N/A

Free Cash Flow

$1.06M

-156.3%

Operating Cash Flow

$1.06M

-156.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LOBEFLobe Sciences Ltd.

LOBEFLobe Sciences Ltd.$0.01-89.42%

BZYRBurzynski Research Institute, Inc.

BZYRBurzynski Research Institute, Inc.$0.02+9.59%

THERTheralink Technologies, Inc.

THERTheralink Technologies, Inc.$0.00+0.00%

BIXTBioxytran, Inc.

BIXTBioxytran, Inc.$0.03-7.98%

KNBIFKane Biotech Inc.

KNBIFKane Biotech Inc.$0.03+38.49%

CUBTCurative Biotechnology, Inc.

CUBTCurative Biotechnology, Inc.$0.95+1.33%

BICXBioCorRx Inc.

BICXBioCorRx Inc.$0.40+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

Questions About BVAXF

What is the current price of BioVaxys Technology?

BioVaxys Technology is trading at $0.05 per share.

What is the 52-week range for BioVaxys Technology?

Over the past 52 weeks, BioVaxys Technology has traded between $0.02 and $0.34.

How much debt does BioVaxys Technology have?

As of the most recent reporting period, BioVaxys Technology reported total debt of $96,719.829.

How much cash does BioVaxys Technology have on hand?

BioVaxys Technology reported $2,951.069 in cash and cash equivalents in its most recent financial results.

What is BioVaxys Technology’s dividend yield?

BioVaxys Technology does not currently have a dividend yield.

BioVaxys Technology

BioVaxys Technology Financials at a Glance

BVAXF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioVaxys Technology

BVAXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioVaxys Technology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BVAXF

What is the current price of BioVaxys Technology?

What is the 52-week range for BioVaxys Technology?

How much debt does BioVaxys Technology have?

How much cash does BioVaxys Technology have on hand?

What is BioVaxys Technology’s dividend yield?

Premium Investing Services